Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEM1777 + Temozolomide in Metastatic Melanoma
NCT00724841Phase 2Terminated
- Sponsor
- Gemin X Pharmaceuticals
- Start
- Jun 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of obatoclax in melanoma, sponsored by Gemin X Pharmaceuticals. Started Jun 2008; status: terminated.
02
Drugs
obatoclax
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00724841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00724841.